MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03056cam a22004092 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
1859594999 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
DE-627 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240515102323.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr uuu---uuuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
230915s2022 xx |||||o 00| ||eng c |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783031054600 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(DE-627)1859594999 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(DE-599)KEP081823606 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(EBC)EBC7078092 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(EBL)EBL7078092 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(EBP)081823606 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DE-627 |
| Language of cataloging |
ger |
| Transcribing agency |
DE-627 |
| Description conventions |
rda |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.80471 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Corasolla Carregari, Victor |
| Relator term |
author |
| Relator code |
aut |
| 9 (RLIN) |
972854 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Understanding PTMs in Neurodegenerative Diseases |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Cham |
| Name of producer, publisher, distributor, manufacturer |
Springer International Publishing AG |
| Date of production, publication, distribution, manufacture, or copyright notice |
2022 |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2022 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
VIII, 146 pages |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
Text |
| Content type code |
txt |
| Source |
rdacontent |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
Advances in Experimental Medicine and Biology Series |
| Volume/sequential designation |
v.1382 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Description based on publisher supplied metadata and other sources |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Intro -- Preface -- Contents -- Chapter 1: Protein Extraction and Sample Preparation Methods for Shotgun Proteomics with Central Nervous System Cells and Brain Tissue -- 1.1 Introduction -- 1.2 Lysis Buffers -- 1.3 Buffer Compositions, Pros, and Cons -- 1.3.1 RIPA Buffer -- 1.3.2 Modified RIPA Buffer -- 1.3.3 SDS Sample Buffer -- 1.3.4 NP-40 Lysis Buffer -- 1.3.5 HEPES Lysis Buffer -- 1.3.6 CHAPS Lysis Buffer -- 1.3.7 Urea Buffer -- 1.3.8 Protease Inhibitor Cocktail -- 1.4 Sample Preparation Methods -- 1.4.1 Central Nervous System (CNS) Cells -- 1.4.2 Postmortem Brain Tissue -- 1.4.3 Cerebrospinal Fluid (CSF) -- 1.5 Digestion Methods for Shotgun Proteomics -- 1.5.1 In-Solution Digestion -- 1.5.2 Homemade C18 Microcolumn -- 1.5.3 Filter-Aided Sample Preparation (FASP) -- 1.5.4 Suspension Trap (S-TRAP) -- 1.6 Conclusions -- References -- Chapter 2: Phosphopeptide Enrichment Techniques: A Pivotal Step for Phosphoproteomic Studies -- 2.1 Introduction -- 2.2 Phosphopeptide Enrichment -- 2.3 IMAC -- 2.4 TiO2 -- 2.5 TiO2 Micro-Column -- 2.6 SIMAC -- 2.7 Conclusion -- References -- Chapter 3: Post-Translational Modifications During Brain Development -- 3.1 Biological Steps of Neurodevelopment and Post-translational Modifications -- 3.2 Post-translational Modifications During Neurodevelopment -- 3.2.1 Cytoskeletal Proteins -- 3.2.2 Gene Transcription and Protein Translation -- 3.2.3 Signaling Pathways -- 3.3 Concluding Remarks -- References -- Chapter 4: Aberrant Protein Glycosylation in Brain Cancers, with Emphasis on Glioblastoma -- 4.1 Introduction -- 4.2 Asparagine N-Linked Glycosylation Family (ALG) -- 4.3 β-1,4-Galactosyltransferase (B4T) and β-1,3-Nacetylglucosaminyltransferase (B3T) Families -- 4.4 Fucosyltransferase Family (FUT) -- 4.5 N-Acetylgalactosaminyltransferase Family (GALNT) -- 4.6 Hexosaminidase Family (HEX). |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Metabolism |
| 9 (RLIN) |
12497 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Nervous system-Degeneration |
| 9 (RLIN) |
972855 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Proteomics |
| 9 (RLIN) |
2076 |
| 951 ## - EQUIVALENCE OR CROSS-REFERENCE-GEOGRAPHIC NAME/AREA NAME [OBSOLETE] [CAN/MARC only] |
|---|
| Geographic name |
BO |
| 776 1# - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| International Standard Book Number |
9783031054594 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |